Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study.

作者: Philipp Schommers , Christoph Wyen , Marcus Hentrich , Daniel Gillor , Alexander Zoufaly

DOI: 10.1097/QAD.0B013E32835E069D

关键词: AIDS-related lymphomaUnivariate analysisCause of deathInternal medicineInternational Prognostic IndexPlasmablastic lymphomaMedicineCohort studyLymphomaProspective cohort study

摘要: Out of 302 AIDS-related lymphoma (ARL) patients enrolled in the German ARL cohort study, 18 had plasmablastic (PBL). Twelve out (67%) have died with a median survival 4 months (range 0-11 months). In univariate analysis, an intermediate or high international prognostic index score was associated significantly lower overall and progression-free survival. The predominant cause death progressive (67%). Our data indicate that outcome PBL is still very poor.

参考文章(25)
H.J. Delecluse, I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti, U. Schneider, D. Huhn, A. Schmidt-Westhausen, P.A. Reichart, U. Gross, H. Stein, Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection Blood. ,vol. 89, pp. 1413- 1420 ,(1997) , 10.1182/BLOOD.V89.4.1413
Mathew Simcock, Monika Blasko, Urs Karrer, Barbara Bertisch, Miklos Pless, Liisa Blumer, Samir Vora, James Owen Robinson, Enos Bernasconi, Benedetta Terziroli, Sophie Moirandat-Rytz, Hansjakob Furrer, Bernard Hirschel, Pietro Vernazza, Pedram Sendi, Martin Rickenbach, Heiner C Bucher, Manuel Battegay, Michael T Koller, Swiss HIV Cohort Study, Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Antiviral Therapy. ,vol. 12, pp. 931- 939 ,(2007)
Jorge J Castillo, Michael Furman, Brady E Beltrán, Michele Bibas, Mark Bower, Weina Chen, José L Díez‐Martín, Jane J Liu, Roberto N Miranda, Silvia Montoto, Nahid M Nanaji, José‐Tomás Navarro, Adam C Seegmiller, Julie M Vose, None, Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer. ,vol. 118, pp. 5270- 5277 ,(2012) , 10.1002/CNCR.27551
Taimur Sher, Kena C. Miller, Kelvin Lee, Asher Chanan-Khan, Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report. Clinical Lymphoma, Myeloma & Leukemia. ,vol. 9, pp. 328- 330 ,(2009) , 10.3816/CLM.2009.N.065
Christian Hoffmann, Holger Schmid, Markus Müller, Christian Teutsch, Jan van Lunzen, Stefan Esser, Timo Wolf, Christoph Wyen, Michael Sabranski, Heinz-August Horst, Stefan Reuter, Martin Vogel, Hans Jäger, Johannes Bogner, Keikawus Arasteh, Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease Blood. ,vol. 118, pp. 3499- 3503 ,(2011) , 10.1182/BLOOD-2011-02-333633
Alessandro Re, Mariagrazia Michieli, Salvatore Casari, Bernardino Allione, Chiara Cattaneo, Maurizio Rupolo, Michele Spina, Rosa Manuele, Emanuela Vaccher, Mario Mazzucato, Luciano Abbruzzese, Pierino Ferremi, Giampiero Carosi, Umberto Tirelli, Giuseppe Rossi, High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors Blood. ,vol. 114, pp. 1306- 1313 ,(2009) , 10.1182/BLOOD-2009-02-202762
Jorge Castillo, Liron Pantanowitz, Bruce J. Dezube, HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases American Journal of Hematology. ,vol. 83, pp. 804- 809 ,(2008) , 10.1002/AJH.21250
Prithviraj Bose, Christopher Thompson, Darshan Gandhi, Bassam Ghabach, Howard Ozer, AIDS‐related plasmablastic lymphoma with dramatic, early response to bortezomib European Journal of Haematology. ,vol. 82, pp. 490- 492 ,(2009) , 10.1111/J.1600-0609.2009.01235.X